Skip to content

Katie Ewer

  • PhD
  • University of Oxford
  • 31h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 4354CitationsNumber of citations received by Katie's publications. Updated daily.

Research interests

MERS-CoVRift valley fever virusinfluenza vaccinesEmerging pathogensAntibodiesCD8+ T cellsCorrelates of vaccine-induced protectionEbolaMalariaImmunologyVaccines

Co-authors (385)

  • Ioanna Giannopoulou
  • Emma Dickinson

Publications (5)

  • Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP

    • Bliss C
    • Bowyer G
    • Anagnostou N
    • et al.
    N/AReaders
    1Citations
    Get full text
  • An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens

    • Rodríguez-Galán A
    • Salman A
    • Bowyer G
    • et al.
    N/AReaders
    1Citations
    Get full text
  • A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA

    • Ewer K
    • Rampling T
    • Venkatraman N
    • et al.
    N/AReaders
    98Citations
    Get full text
  • Safety and immunogenicity of novel adenovirus type 26-and modified vaccinia Ankara-vectored Ebola vaccines: A randomized clinical trial

    • Milligan I
    • Gibani M
    • Sewell R
    • et al.
    N/AReaders
    56Citations
    Get full text
  • Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults

    • Ogwang C
    • Kimani D
    • Edwards N
    • et al.
    N/AReaders
    43Citations
    Get full text

Editorships

Peer J

Editorial Board (Immunology)

2017 - Present

Professional experience

University of Oxford